| 翻訳と辞書 |
| Richard Roberts (pharmaceutical executive) ： ウィキペディア英語版 |
Richard Roberts (pharmaceutical executive)
Richard H. Roberts (born 1957) is an American pharmaceutical executive, philanthropist, and political activist.
==Biography==
Born in a secular Jewish family Philadelphia in 1957 and raised in Abington Township, Pennsylvania, the son of Albert Roberts. His father, a chemist, started URL Pharma in 1946 which manufactured steroidal hormones that treated pain by collecting pig pituitary glands from slaughterhouses.〔 Roberts earned a M.D. and a Ph.D. from the University of Pennsylvania.〔 After school, he took over his father’s money-losing pharmaceutical company.〔 In 1997, he sold majority control of the firm to several venture capital firms which left him as the CEO of the company with a ~30% ownership interest.〔
In 2009, the FDA approved colchicine as a monotherapy for the treatment of three different indications (familial Mediterranean fever, acute gout flares, and for the prophylaxis of gout flares) and gave URL Pharma a three-year marketing exclusivity agreement〔(【引用サイトリンク】title=Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations )〕 in exchange for URL Pharma doing 17 new studies and investing $100 million into the product (of which $45 million went to the FDA for the application fee). URL Pharma subsequently raised the price from $0.09 per tablet to $4.85; and in October 2010, the FDA removed the older unapproved colchicine (in both in oral and intravenous forms) from the market (although they allowed pharmacies the opportunity to buy up the older unapproved colchicine).〔(【引用サイトリンク】title=Questions and Answers for Patients and Healthcare Providers Regarding Single-ingredient Oral Colchicine Products )〕 Richards indicated that the price increase mirrored other approved and branded drugs that were used to treat gout pain. URL Pharma returned to profitability〔 with its gout treatment branded Colcrys consisting of 72% of the companies $600 million in sales in 2011.〔 Roberts sold URL Pharma for $800 million in June 2012 to Takeda Pharmaceuticals of Japan.〔
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Richard Roberts (pharmaceutical executive)」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|